[Biopharmaceutical studies on molecular mechanisms of membrane transport].
[Biopharmaceutical studies on molecular mechanisms of membrane transport].
复制标题
膜转运分子机制的生物制药研究。
DOI:
--
复制
发表时间:
2002
期刊:
影响因子:
--
通讯作者:
A. Tsuji
中科院分区:
文献类型:
--
作者:
A. Tsuji
By incorporating the transporter-mediated or receptor-mediated transport process in physiologically based pharmacokinetic models, we succeeded in the quantitative prediction of plasma and tissue concentrations of beta-lactam antibiotics, insulin, pentazocine, quinolone antibacterial agents, and inaperizone and digoxin. The author's research on transporter-mediated pharmacokinetics focuses on the molecular and functional characteristics of drug transporters such as oligopeptide transporter, monocarboxylic acid transporter, anion antiporter, organic anion transporters, organic cation/carnitine transporters (OCTNs), and the ATP-binding cassette transporters P-glycoprotein and MRP2. We have successfully demonstrated that these transporters play important roles in the influxes and/or effluxes of drugs in intestinal and renal epithelial cells, hepatocytes, and brain capillary endothelial cells that form the blood-brain barrier. In the systemic carnitine deficiency (SCD) phenotype mouse model, juvenile visceral steatosis (jvs) mouse, a mutation in the OCTN2 gene was found. Furthermore, several types of mutation in human SCD patients were found, demonstrating that OCTN2 is a physiologically important carnitine transporter. Interestingly, OCTNs transport carnitine in a sodium-dependent manner and various cationic drugs transport it in a sodium-independent manner. OCTNs are thought to be multifunctional transporters for the uptake of carnitine into tissue cells and for the elimination of intracellular organic cationic drugs.
DOI:
10.1006/bbrc.1998.9298
发表时间:
1998-09-18
影响因子:
3.1
作者:
Balimane, PV;Tamai, I;Sinko, PJ
通讯作者:
Sinko, PJ